Notably, although VEGF has been mainly used as the main target for the treatment of aberrant blood vessel growth in the past, the ANG-TIE-2 pathway has also gradually shown its potential in anti-tumor induced angiogenesis. The gene discussed is TEK; the disease is neoplasm.